van der Horst Edward has filed 10 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 2276 shares of Sensei Biotherapeutics, Inc. ($SNSE) on February 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 2276 | $0.48 | 59,794.0000 | 25,117,238 | 3.67% | 0.01% |
| Feb. 14, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 25,117,238 | 9999.99% | 0.44% |
| Dec. 20, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 1,257,299 | 9999.99% | 7.95% |
| Feb. 15, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 2843 | $0.79 | 56,070.0000 | 27,952,857 | 4.83% | 0.01% |
| Feb. 15, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 27,952,857 | 9999.99% | 0.45% |
| Feb. 15, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 90102 | $0.00 | 90,102.0000 | 27,952,857 | 9999.99% | 0.32% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | Chief Scientific Officer | F | Common Stock | 9525 | $1.50 | 52,913.0000 | 0 | 15.26% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | Chief Scientific Officer | A | Common Stock | 23565 | $0.00 | 44,738.0000 | 0 | 111.30% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | Chief Scientific Officer | A | Common Stock | 17700 | $0.00 | 62,438.0000 | 0 | 39.56% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | van der Horst Edward | Chief Scientific Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |